Michael K. Essandoh

Dr. Michael K. Essandoh

Department of Anesthesiology, Ohio State University Medical Center, Columbus, OH, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MEMichael K. Essandoh
Michael K. Essandoh
NKNicolas Kumar
Nicolas Kumar
NHNasir Hussain
Nasir Hussain
ADAdam A. Dalia
Adam A. Dalia
DWDavid Wang
David Wang
MIManoj H. Iyer
Manoj H. Iyer

1 April 2018 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
ADAdam A. Dalia
Adam A. Dalia
BCBrett Cronin
Brett Cronin
MSMarc E. Stone
Marc E. Stone
KTKatja Turner
Katja Turner
JHJennifer Hargrave
Jennifer Hargrave
MEMichael K. Essandoh
Michael K. Essandoh

1 October 2016 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Open access
MEMichael K. Essandoh
Michael K. Essandoh
AOAndrew J. Otey
Andrew J. Otey
MAMahmoud Abdel-Rasoul
Mahmoud Abdel-Rasoul
ESErica J. Stein
Erica J. Stein
KTKatja R. Turner
Katja R. Turner
EDEmile G. Daoud
Emile G. Daoud
To date, general anesthesia has been suggested as the preferred approach for implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD). The purpose of this study was to assess the use of monitored anesthesia care (MAC) for S-ICD implantation. The goals were to assess adequate sedation and analgesia (efficacy endpoints) and major perioperative airway or hemodynamic compromise (safety endpoints). The authors hypothesized that MAC may provide adequate sedation and analgesia and no major perioperative airway or hemodynamic compromise during S-ICD implantation and multiple defibrillation threshold (DFT) testing. Prospectively collected data of patients who underwent S-ICD implantation with MAC from 2015 to 2016 were analyzed retrospectively. The efficacy endpoints were the provision of an optimal depth of sedation and analgesia to facilitate S-ICD implantation without intra-procedure patient discomfort or awareness, and the absence of "severe" pain at the lead tunneling and the generator insertion sites post-procedure. The safety endpoints included: (1) periprocedural hypotension, as defined by a mean arterial pressure (MAP)<60 mmHg refractory to conventional pharmacotherapy, (2) heart rate (HR)<45 bpm requiring pharmacologic support, and (3) sedation-induced airway compromise requiring endotracheal intubation. MAP and HR were recorded during S-ICD implantation and DFT testing. The maximum and minimum infusion rates of propofol, supplemental sedatives, and analgesics, and doses of vasopressor and/or inotropic agents administered intra-procedurally were recorded. Post-procedure pain scores also were noted. Ten patients underwent S-ICD implantation with MAC (mean age, 56 years; 50% men; mean left ventricular ejection fraction was 39%). Implantation of the S-ICD system using MAC was successful in all patients without any major adverse events. The mean baseline MAP was 92.8 mmHg, and the mean end-procedure MAP was 88 mmHg (p = 0.26). When compared to baseline and end-procedure, the mean lowest intra-procedure MAP was significantly lower (67.4 mmHg; p = 0.0001). The mean baseline HR was 65.7 bpm, and the mean end-procedure HR was 70.1 bpm (p = 0.28). When compared to baseline and end-procedure, the mean lowest intra-procedure HR was significantly lower (55.8 bpm; p<0.001). MAC was not associated with airway compromise in any patient, and post-procedure pain was rated as no greater than "mild". Among a heterogeneous patient population undergoing S-ICD implantation and DFT testing, the use of MAC is efficacious, feasible, and safe.

1 June 2016 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
MEMichael K. Essandoh
Michael K. Essandoh
JPJuan G. Portillo
Juan G. Portillo
RWRaul Weiss
Raul Weiss
AOAndrew J. Otey
Andrew J. Otey
AZAlix N. Zuleta-Alarcon
Alix N. Zuleta-Alarcon
EDEmile G. Daoud
Emile G. Daoud

3 June 2020 in Current Heart Failure Reports
Verified
Journal Article
Closed access
PDF file
MGMatthew L. Goodwin
Matthew L. Goodwin
CBChristopher M. Bobba
Christopher M. Bobba
NMNahush A. Mokadam
Nahush A. Mokadam
BWBryan A Whitson
Bryan A Whitson
MEMichael K. Essandoh
Michael K. Essandoh
AGAsvin M Ganapathi
Asvin M Ganapathi

22 June 2023 in Seminars in Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NKNicolas Kumar
Nicolas Kumar
JMJustin Mitchell
Justin Mitchell
ASAndrew Siemens
Andrew Siemens
SDSelina Deiparine
Selina Deiparine
DSDaniel Saddawi-Konefka
Daniel Saddawi-Konefka
DHDavid Hao
David Hao
Background. The EZ-Blocker is the newest generation of bronchial blocker and offers a potential alternative to left-sided double lumen tubes for lung isolation and one-lung ventilation during thoracic surgery. Methods. Databases were searched for randomized controlled trials comparing left-sided double lumen tube to the EZ-Blocker for one-lung ventilation during thoracic surgery. The time for placement, incidence of intraoperative displacement, and surgeons’ rating of lung collapse quality were designated as coprimary outcomes. The safety profiles of the two devices, including the incidence of airway trauma and post-extubation discomfort were also examined. Results. Six randomized controlled trials (495 patients) were analyzed. Compared to the EZ-Blocker, the left-sided double lumen tube was faster to place by a weighted mean difference of [95% CI] of −61.24 seconds [−102.48, −20.00] (P = .004) and was much less likely to become displaced during lung isolation with an odds ratio [95% CI] of .56 [.34, .91] (P = .02). The left-sided double lumen tube and the EZ-Blocker provided similar surgeon-rated quality of lung isolation. Although the left-sided double lumen tube caused a greater degree of post-extubation sore throat, there was a similar incidence of carinal trauma and post-extubation hoarseness compared to the EZ-Blocker. Conclusion. Our analysis suggests that the left-sided double lumen tube can be placed more quickly and is less prone to intraoperative displacement compared to the EZ-Blocker; the quality of lung collapse is similar. Thus, evidence appears to support the continued utilization of the left-sided double lumen tube for routine thoracic surgery requiring one-lung ventilation.